Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 1
1979 1
1981 1
1982 1
1983 1
1984 1
1985 1
1986 4
1987 1
1988 2
1989 4
1990 2
1991 1
1992 3
1993 2
1994 3
1995 1
1996 4
1997 4
1998 2
1999 3
2000 4
2001 3
2002 3
2003 3
2004 2
2005 2
2007 5
2008 4
2009 4
2010 6
2011 8
2012 6
2013 7
2014 5
2015 4
2016 9
2017 6
2018 9
2019 4
2020 7
2021 11
2022 16
2023 7
2024 15
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for taps dt
Search for Tapps DT instead (1 results)
Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial.
Woller SC, Stevens SM, Kaplan D, Wang TF, Branch DW, Groat D, Wilson EL, Armbruster B, Aston VT, Lloyd JF, Rondina MT, Elliott CG. Woller SC, et al. Blood Adv. 2022 Mar 22;6(6):1661-1670. doi: 10.1182/bloodadvances.2021005808. Blood Adv. 2022. PMID: 34662890 Free PMC article. Clinical Trial.
Thrombotic antiphospholipid syndrome (TAPS) is characterized by venous, arterial, or microvascular thrombosis. Patients with TAPS merit indefinite anticoagulation, and warfarin has historically been the standard treatment. ...The efficacy and safety of apixaban comp …
Thrombotic antiphospholipid syndrome (TAPS) is characterized by venous, arterial, or microvascular thrombosis. Patients with TAPS …
Bleeding TAPs out.
Ngo ATP, Aslan JE, McCarty OJT. Ngo ATP, et al. J Thromb Haemost. 2019 Feb;17(2):247-249. doi: 10.1111/jth.14340. Epub 2018 Dec 13. J Thromb Haemost. 2019. PMID: 30549218 Free article. No abstract available.
Severe Intraocular Inflammation Following Intravitreal Faricimab.
Thangamathesvaran L, Kong J, Bressler SB, Singh M, Wenick AS, Scott AW, Arévalo JF, Bressler NM. Thangamathesvaran L, et al. JAMA Ophthalmol. 2024 Apr 1;142(4):365-370. doi: 10.1001/jamaophthalmol.2024.0530. JAMA Ophthalmol. 2024. PMID: 38421861 Free PMC article.
MAIN OUTCOMES AND MEASURES: Visual acuity, vitreous taps for bacterial or fungal cultures, and retinal imaging. RESULTS: All 3 patients received intravitreal faricimab injections between September 20 and October 20, 2023, from 2 different lot numbers (expiration dates, Jul …
MAIN OUTCOMES AND MEASURES: Visual acuity, vitreous taps for bacterial or fungal cultures, and retinal imaging. RESULTS: All 3 patien …
[Acute retinal necrosis].
Winterhalter S, Adams O, Althaus Ch, Stammen J, Schöler EM, Joussen AM. Winterhalter S, et al. Klin Monbl Augenheilkd. 2007 Jul;224(7):567-74. doi: 10.1055/s-2007-963182. Klin Monbl Augenheilkd. 2007. PMID: 17657690 Review. German.
Confirmation of the early diagnosis through polymerase chain reaction and antibody detection from aqueous or vitreous taps is recommended to improve the medical management and prevent disease progression with an increased risk of complications. ...
Confirmation of the early diagnosis through polymerase chain reaction and antibody detection from aqueous or vitreous taps is recomme …
Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review.
Fernandes R, Mazzarello S, Hutton B, Shorr R, Majeed H, Ibrahim MF, Jacobs C, Ong M, Clemons M. Fernandes R, et al. Support Care Cancer. 2016 Aug;24(8):3633-50. doi: 10.1007/s00520-016-3256-5. Epub 2016 May 5. Support Care Cancer. 2016. PMID: 27146496
BACKGROUND: Taxane acute pain syndrome (TAPS) is characterized by myalgias and arthralgias starting 24-48 h after taxane-based chemotherapy and lasting for 5-7 days. ...Three out of eight studies assessing quality of life demonstrated pain interference with daily activitie …
BACKGROUND: Taxane acute pain syndrome (TAPS) is characterized by myalgias and arthralgias starting 24-48 h after taxane-based chemot …
Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy-a systematic review.
Fernandes R, Mazzarello S, Majeed H, Smith S, Shorr R, Hutton B, Ibrahim MF, Jacobs C, Ong M, Clemons M. Fernandes R, et al. Support Care Cancer. 2016 Apr;24(4):1583-94. doi: 10.1007/s00520-015-2941-0. Epub 2015 Sep 19. Support Care Cancer. 2016. PMID: 26386706
BACKGROUND: Taxane acute pain syndrome (TAPS) is characterized by myalgias and arthralgias starting 1-3 days and lasting 5-7 days after taxane-based chemotherapy. Despite negatively impacting patient's quality of life, little is known about the optimal TAPS manageme …
BACKGROUND: Taxane acute pain syndrome (TAPS) is characterized by myalgias and arthralgias starting 1-3 days and lasting 5-7 days aft …
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study.
Dekker EN, van Dam JL, Janssen QP, Besselink MG, DeSilva A, Doppenberg D, van Eijck CHJ, Nasar N, O'Reilly EM, Paniccia A, Prakash LR, Tzeng CD, Verkolf EMM, Wei AC, Zureikat AH, Katz MHG, Groot Koerkamp B; Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. Dekker EN, et al. J Clin Oncol. 2024 Apr 20;42(12):1357-1367. doi: 10.1200/JCO.23.01311. Epub 2024 Feb 5. J Clin Oncol. 2024. PMID: 38315954
Selective apoptosis of tumor-associated platelets boosts the anti-metastatic potency of PD-1 blockade therapy.
Wu S, Wu Z, Lu Z, Qi F, Cheng J, Chu T, Li B, Zhao Y, Nie G, Li S. Wu S, et al. Cell Rep Med. 2025 Mar 18;6(3):101984. doi: 10.1016/j.xcrm.2025.101984. Epub 2025 Feb 27. Cell Rep Med. 2025. PMID: 40020674 Free PMC article.
Despite the transformative impact of programmed cell death protein-1 (PD-1) blockade therapy on metastatic/advanced solid tumor treatment, its efficacy is hindered by a limited response rate. ...Our study underscores the importance of depleting TAPs to enhance PD-1 …
Despite the transformative impact of programmed cell death protein-1 (PD-1) blockade therapy on metastatic/advanced solid tumor treat …
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents.
Dhas Y, Biswas N, M R D, Jones LD, Ashili S. Dhas Y, et al. Mol Biomed. 2024 Sep 28;5(1):40. doi: 10.1186/s43556-024-00204-z. Mol Biomed. 2024. PMID: 39333445 Free PMC article. Review.
Drug repurposing in cancer taps into the capabilities of existing drugs, initially designed for other ailments, as potential cancer treatments. It offers several advantages over traditional drug discovery, including reduced costs, reduced development timeline …
Drug repurposing in cancer taps into the capabilities of existing drugs, initially designed for other ailments, as potential c …
Primary writing tremor.
Bain PG, Findley LJ, Britton TC, Rothwell JC, Gresty MA, Thompson PD, Marsden CD. Bain PG, et al. Brain. 1995 Dec;118 ( Pt 6):1461-72. doi: 10.1093/brain/118.6.1461. Brain. 1995. PMID: 8595477
A family history of PWT was obtained from seven patients. Ten patients obtained benefit from drug treatment (mainly propranalol or primidone) and seven responded to alcohol. The writing speeds of the patients (mean +/- SEM: 73.1 +/- 6.6 letters per minute) when using their …
A family history of PWT was obtained from seven patients. Ten patients obtained benefit from drug treatment (mainly propranalol or pr …
183 results